2 weeks Ago By Defense World Staff
Brandes Investment Partners LP lifted its position in Phibro Animal Health Co. ( NASDAQ:PAHC – Free Report ) by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).
The firm owned 2,405,629 shares of the company’s stock after purchasing an additional 29,071 shares during the period. Brandes Investment Partners LP owned about 5.94% of Phibro Animal Health worth $40,521,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund raised its position in shares of Phibro Animal Health by 7.2% in the first quarter.
Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after acquiring an additional 765 shares during the period. CWM LLC boosted its position in Phibro Animal Health by 89.8% during the second quarter.
CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Phibro Animal Health by 7.
4% in the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after purchasing an additional 1,063 shares during the period.
China Universal Asset Management Co. Ltd. grew its holdings in Phibro Animal Health by 65.
0% in the first quarter. China Universal Asset Management Co. Ltd.
now owns 3,888 shares of the company’s stock valued at $50,000 after purchasing an additional 1,531 shares during the period. Finally, Cardinal Capital Management increased its position in shares of Phibro Animal Health by 4.7% in the second quarter.
Cardinal Capital Management now owns 56,027 shares of the company’s stock valued at $940,000 after buying an additional 2,520 shares in the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes A number of brokerages have recently issued reports on PAHC. Bank of America increased their target price on Phibro Animal Health from $13.00 to $15.
00 and gave the company an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th.
They set a “neutral” rating and a $22.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock.
According to MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and an average price target of $15.00. Insider Buying and Selling at Phibro Animal Health In other news, Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th.
The stock was acquired at an average price of $20.02 per share, with a total value of $100,100.00.
Following the purchase, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. The acquisition was disclosed in a document filed with the SEC, which is available at this link . 50.
06% of the stock is owned by company insiders. Phibro Animal Health Stock Down 0.1 % Shares of PAHC opened at $22.
07 on Monday. The stock has a 50 day moving average price of $19.75 and a 200 day moving average price of $17.
23. Phibro Animal Health Co. has a one year low of $9.
40 and a one year high of $22.76. The company has a debt-to-equity ratio of 1.
79, a quick ratio of 1.64 and a current ratio of 2.94.
The stock has a market capitalization of $893.84 million, a price-to-earnings ratio of 68.97, a PEG ratio of 1.
77 and a beta of 0.52. Phibro Animal Health ( NASDAQ:PAHC – Get Free Report ) last issued its earnings results on Wednesday, August 28th.
The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.34 by $0.
07. The business had revenue of $273.16 million during the quarter, compared to analysts’ expectations of $262.
44 million. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.
08%. Equities research analysts forecast that Phibro Animal Health Co. will post 1.
44 earnings per share for the current fiscal year. Phibro Animal Health Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th were issued a dividend of $0.
12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.
17%. The ex-dividend date of this dividend was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio is currently 150.
00%. About Phibro Animal Health ( Free Report ) Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. Further Reading Five stocks we like better than Phibro Animal Health P/E Ratio Calculation: How to Assess Stocks 3 Bargain Stocks Under $20 With Major Growth Potential Financial Services Stocks Investing Top 5 ETFs to Own Now and Into 2025 Best Stocks Under $5.00 Watch These 3 Former Short-Squeeze Stocks for a Big Rally Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.
com's FREE daily email newsletter ..
